tirzepatide side effects long-term Zepbound (Tirzepatide) Effects: Common & Zepbound (tirzepatide) Side Effects: Mild

Gastrointestinal side effects are the most commonly reported adverse reactions with GLP-1 receptor agonists

doi: 10.1002/alz.088069

The peak is middle age More than 1 in 5 adults aged 50 to 64 (22%) currently take a GLP-1, against just 4% of adults under 30

We do our best to make sure all the information that we provide on this site is correct

Pipeline report flags continued pressure The insurer's annual outlook, aimed at private plan sponsors, lists GLP-1 therapies among the leading themes of 2026 and warns that ongoing launches of newer, more expensive drugs are putting increased financial pressure on private drug plans

Mitochondrion 13:163169 Ethics declarations Competing interests The authors declare no competing interests